| Application no. and date | 20215786.3 (espacenet) (Federated) (European Patent Register), 20170126 | | Patent/reg. no. and date | DK/EP 3838274, 20231101 | | Publication date | 20210623 | | Priority no. and date | US 201662287264 P, 20160126, US 201662440130 P, 20161229 | | EP pub. no. and date |
EP 3838274 20210623 | | Effective date | | | Applicant/owner | Intra-Cellular Therapies, Inc., 430 East 29th Street, Suite 900
New York, NY 10016, US | | Applicant ref. no. | LUPV1448573/EP-DK-AZA | | Inventor | LI, Peng, Intra-Cellular Therapies, Inc.
430 East 29th Street, Suite 900
New York, New York 10016, US,
YAO, Wei, Intra-Cellular Therapies, Inc.
430 East 29th Street, Suite 900
New York, New York 10016, US | | Representative | Dennemeyer & Associates S.A, P.O. Box 700425
DE-81304 Munich, DE | | Opponent | | | IPC Class | A61K 31/445 (2006.01) , A61K 31/4985 (2006.01) , A61P 25/00 (2006.01) | | Title | PYRIDO[3',4':4,5]PYRROLO[1,2,3-DE]QUINOXALIN-DERIVAT TIL BRUG TIL BEHANDLING AF CNS-LIDELSER | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
